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Abstract
Repeated exposure to cocaine increases the density of dendritic spines on medium spiny neurons in the nucleus accumbens (Acb)
and pyramidal cells in the medial prefrontal cortex (mPFC). To determine if this is associated with the development of psychomotor
sensitization, rats were given daily i.p. injections of 15 mg ⁄ kg of cocaine (or saline) for 8 days, either in their home cage (which failed
to induce significant psychomotor sensitization) or in a distinct and relatively novel test cage (which induced robust psychomotor
sensitization). Their brains were obtained 2 weeks after the last injection and processed for Golgi–Cox staining. In the Acb core
(AcbC) cocaine treatment increased spine density only in the group that developed psychomotor sensitization (i.e. in the Novel but
not Home group), and there was a significant positive correlation between the degree of psychomotor sensitization and spine density.
In the Acb shell (AcbS) cocaine increased spine density to the same extent in both groups; i.e. independent of psychomotor
sensitization. In the mPFC cocaine increased spine density in both groups, but to a significantly greater extent in the Novel group.
Furthermore, when rats were treated at Home with a higher dose of cocaine (30 mg ⁄ kg), cocaine now induced psychomotor
sensitization in this context, and also increased spine density in the AcbC. Thus, the context in which cocaine is experienced
influences its ability to reorganize patterns of synaptic connectivity in the Acb and mPFC, and the induction of psychomotor
sensitization is associated with structural plasticity in the AcbC and mPFC, but not the AcbS.
Introduction
Repeated intermittent exposure to drugs of abuse can render animals
hypersensitive (sensitized) to some drug effects, and to drug-related
stimuli, even long after the discontinuation of drug treatment (Segal &
Mandell, 1974; Robinson & Becker, 1986). Most studies have focused
on the psychomotor activating effects of drugs (psychomotor
sensitization), but repeated treatment with psychomotor stimulant
drugs also facilitates Pavlovian conditioned motivational processes
(Harmer & Phillips, 1998, 1999; Taylor & Horger, 1999; Wyvell &
Berridge, 2001), the later acquisition of drug self-administration
(Piazza et al., 1989; Horger et al., 1990; Pierre & Vezina, 1998), the
acquisition of a preference for places associated with drug adminis-
tration (Lett, 1989) and the ‘breakpoint’ achieved on a progressive
ratio schedule (Mendrek et al., 1998; Lorrain et al., 2000). On the
basis of these studies (for a review, see Vezina, 2004) it has been
hypothesized that drug-induced adaptations in the brain associated
with the induction of behavioural sensitization contribute to the
development of addiction (Robinson & Berridge, 1993, 2003).
There has therefore been considerable interest in the neurobiology
of sensitization, and many neurobiological correlates of sensitization
have been reported, especially in the nucleus accumbens (Acb) and
associated circuitry (Pierce & Kalivas, 1997; Vanderschuren &
Kalivas, 2000). In most previous studies designed to identify
neurobiological correlates of sensitization a drug is given repeatedly
and then later the brain is examined to determine if drug treatment
produced any persistent change in the neurobiological measure of
interest. However, in such studies it is not possible to tell if any given
drug-induced neuroadaptation is related specifically to the develop-
ment of behavioural sensitization, or whether it would occur even if
drug treatments failed to induce sensitization (i.e. as a function of mere
drug history). We have developed a procedure to do this. There are
doses of amphetamine or cocaine that are relatively ineffective in
producing psychomotor sensitization if given in an animal’s home
cage, but induce robust psychomotor sensitization if given in a distinct
and relatively novel test cage (Badiani et al., 1995; Crombag et al.,
1996; Browman et al., 1998a). Thus, in this situation two randomly
assigned groups (Home vs. Novel) have the same drug history, but
only one group develops robust psychomotor sensitization. If any
given drug-induced change in the brain is associated with the
development of sensitization it should be present in the Novel, but not
the Home group; unless dose is increased so that now drug treatments
induce sensitization even at Home (Browman et al., 1998a,b).
The purpose of the present experiment was to manipulate the
induction of psychomotor sensitization by varying environmental
context and dose to determine whether one neurobiological conse-
quence of exposure to cocaine, its ability to alter synaptic organization
in the Acb and the medial frontal cortex (mPFC) (Robinson & Kolb,
1999; Robinson et al., 2001) is related to its ability to induce
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psychomotor sensitization, or whether cocaine induces this form of
structural plasticity independent of its ability to induce sensitization
(i.e. merely as a function of drug history)1 .
Methods
Male Sprague–Dawley rats (200–225 g) obtained initially from Harlan
(Indianapolis, IN, USA) were housed individually in an animal colony
room (14-h light : 10-h dark cycle) in clear plastic hanging cages
(24 · 21.6 · 20.3 cm) with shredded paper bedding for 7 days prior
to any experimental manipulation. Food and water were available at
all times. All experimental procedures were approved by the
University of Michigan Committee on the Use and Care of Animals.
Experiment 1
Procedures
After 7 days, rats were assigned randomly to one of two groups. Rats
in one group (Home) were transferred from the animal colony to a
room where they were housed in transparent plastic rectangular cages
(41 · 25.4 · 20.3 cm) that contained a clear plastic insert in the
centre of the cage (23 · 6.3 · 20.3 cm). This insert formed a corridor
around the perimeter of the cage where the animals could walk.
Ground corncob bedding was located on the floor. These cages were
located inside a frame that contained photocell emitters and detectors
that could be used to record the movement of an animal from one end
of the cage to the other (crossovers). The animals remained in these
cages for the duration of the experiment. Animals in the other group
(Novel) were left in the animal colony room.
After seven additional days of habituation to these conditions,
during which time all animals were periodically handled, rats in the
Novel group were transferred from their home cages to photocell-
equipped test cages that were identical to the ones in which the Home
group lived. After 60 min in these test cages, the animals were given
an intraperitoneal (i.p.) injection of either 1 mL ⁄ kg of 0.9% saline2
(Novel ⁄ Saline, n ¼ 8) or 15 mg ⁄ kg of cocaine HCl3 (Novel ⁄Cocaine,
n ¼ 12; cocaine from NIDA) and behaviour recorded for an additional
90 min before the animals were returned to their home cages in the
animal colony room. This procedure was repeated each day for a total
of eight consecutive days. At the same time as the animals in the
Novel group received an injection, animals in the Home group were
also given an i.p. injection of either saline (Home ⁄ Saline, n ¼ 8) or
15 mg ⁄ kg of cocaine (Home ⁄Cocaine, n ¼ 12), and were then placed
immediately back into their home cage and behaviour monitored.
After the last injection of saline or cocaine, the animals were left
undisturbed for 2 weeks before their brains were obtained.
Experiment 2
Procedures
The procedures for this experiment were exactly the same as for
experiment 1, except for the following modifications: (i) there was
only a Home group, and half of these animals received cocaine
(n ¼ 12) and half saline (n ¼ 11); (ii) on the first test day, cocaine-
treated animals received injections of escalating doses of cocaine (7.5,
15 and 30 mg ⁄ kg), with 1 h between each injection (and saline-treated
animals received three injections of saline). On each of the next seven
daily test sessions, the animals received a single injection of
30 mg ⁄ kg of cocaine (or saline). On the last test day, cocaine-treated
animals again received escalating doses of cocaine (7.5, 15 and
30 mg ⁄ kg), with 1 h between each injection (and saline-treated
animals received three injections of saline). This procedure allows the
construction of a dose–response4 function on the first and last day of
treatment. Sensitization is indicated by a shift to the left in the dose–
response function. As in experiment 1, the animals were left
undisturbed for 2 weeks after the last test session before their brains
were obtained.
Note that in these experiments we did not test independent groups
of animals after 2 weeks of withdrawal to ensure that sensitization
persisted in the Novel group and did not appear in a delayed fashion in
the Home group (e.g. there were no saline-treated groups that received
a drug challenge). This was because we have reported the effects of a
withdrawal period in seven different published papers using these
procedures, many involving multiple behavioural experiments. In all
cases the Home ⁄Novel difference described here was also evident
after a period of withdrawal (Badiani et al., 1995; Crombag et al.,
1996; Browman et al., 1998a). Therefore, we were confident this
would be the case here as well, and did not run independent groups to
limit the number of animals used.
Anatomical procedures
After the 2-week drug-free period, the animals were deeply anaes-
thetized with an overdose of sodium pentobarbital5 and perfused
through the heart with 0.9% saline. The brains were removed and
placed in vials containing Golgi–Cox solution (Gibb & Kolb, 1998)
and after 14 days transferred to vials containing a 30% sucrose
solution. After at least 3 days in the sucrose solution, the brains were
cut into 200-lm thick coronal sections using a vibrating microtome,
and stained using procedures described by Gibb & Kolb (1998).
We focused our analyses on medium spiny neurons in the shell of
the nucleus accumbens (AcbS) and the core of the nucleus accumbens
(AcbC), because (i) these regions are embedded in very different
circuitry (Groenewegen et al., 1991; Zahm, 2000) (ii) they play
different roles in the behaviours and psychological processes that
undergo sensitization (Cardinal et al., 2002) and (iii) repeated drug
treatments have different effects on the AcbC and AcbS (Cadoni & Di
Chiara, 2000; Cadoni et al., 2000). In experiment 1, we analysed
pyramidal cells in the mPFC as well, because we previously found
sensitization-related structural adaptations in these cells (Robinson &
Kolb, 1997, 1999).
Note that experiments 1 and 2 were conducted  1 year apart and
the tissue was analysed using different scopes and procedures (e.g.
neurolucida software was used in experiment 1 with a final
magnification of 4000· and in experiment 2 manual camera lucida
procedures with a final magnification of 2000· were used), although
the same experimenter (Li) conducted the anatomical analysis in both
experiments.
In experiment 1, a Leica model DMRE microscope equipped
with an Ludl XYZ motorized stage and neurolucida software
(http://www.microbrightfield.com) was used to identify cells, trace
dendritic segments and count dendritic spines. Cells from each
brain region were first identified at low power (100–125·). To be
included in the analyses, the dendritic tree of a cell had to be well-
stained and visible, and not obscured by blood vessels, glia or other
cells. Given the relatively small number of cells that were well-
stained and met these criteria, nearly all the available cells in a
given section were included in the analyses. In addition, cells were
sampled over the entire extent of the AcbC and AcbS, so the
sample does reflect any specific subregion within these structures.
Most importantly, the person who selected and analysed cells (Li)
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was blind to the experimental condition, so the same criteria were
applied to all groups. Thus, any variation in spine density due to
variation in the location of cells contributed to the experimental
error effect.
For medium spiny neurons, one third-order (or greater) terminal tip
was identified, and the total number of visible spines along the length
of the dendritic segment (at least 20-lm long) were counted. This was
performed with a total magnification on the scope of 1600·, and with
additional magnification from the video signal the final magnification
on the video screen was  4000·. We focused on third order or greater
terminal dendritic segments because we found previously that
amphetamine treatment increases spine density on distal, but not
proximal, dendrites of medium spiny neurons (Li et al., 2003). For
pyramidal cells, spines were counted on one terminal tip per neuron
(third order or greater) from both the apical and basilar dendritic tree.
The neurolucida program calculated the total length of the
dendritic segment and the number of spines ⁄ 10 lm of dendrite. These
measures were obtained from at least five cells in each hemisphere of
each animal, and statistical analyses were conducted after averaging
across cells within a hemisphere (i.e. hemisphere was the unit of
analysis). In experiment 1, the data represent a total sample of 385
cells in the AcbC, 391 cells in the AcbS, 314 (for apical dendrites) and
346 (for basilar dendrites) cells in the mPFC. Data were not available
for every hemisphere in every brain region because of tissue damage
or poor staining, and therefore, the n for the saline-treated groups
varies from 14–16, and for the cocaine-treated groups from 20–24. In
experiment 2, cell selection and quantification was the same as in
experiment 1, except conventional camera lucida procedures were




Figure 1 shows the number of cage crossovers, an index of locomotor
activity, during the first and last (8th) test session in animals treated
with cocaine or saline. A two-way anova comparing the two groups
that received cocaine resulted in a significant main effect of group
(F ¼ 11.99, P < 0.002), of test session (F ¼ 27.17, P < 0.0001), and
a significant group · test session interaction (F ¼ 14.92, P < 0.002).
Planned between-subjects comparisons indicated that there was no
difference between the Home ⁄Cocaine and Novel ⁄Cocaine groups on
the first day of testing (t ¼ 0.53, P ¼ 0.6), but there was on the last
day of testing (t ¼ 3.86, P ¼ 0.0009). Planned within-subjects paired
t-tests showed that there was a significant increase in crossovers
between day 1 and day 8 of testing in the Novel ⁄Cocaine group
(t ¼ 5.28, P ¼ 0.0003), but not in the Home ⁄Cocaine group
(t ¼ 1.08, P ¼ 0.3). Thus, only the Novel ⁄Cocaine group showed
behavioural sensitization, and the Novel ⁄Cocaine group changed over
time to a greater extent than the Home ⁄Cocaine group (as indicated by
the interaction effect).
Anatomy
Nucleus accumbens. Figure 2 shows the effect of cocaine treatment
on the density of dendritic spines on medium spiny neurons in the
AcbC and AcbS. For the AcbC, a two-way anova resulted in a
significant group by drug interaction (F ¼ 6.1, P ¼ 0.016). Post-hoc
Fisher’s tests indicated that cocaine significantly increased spine
density in the Novel group (P < 0.0001), but not in the Home group
(P ¼ 0.78). For the AcbS a two-way anova resulted in no significant
effect of group (Home vs. Novel, F ¼ 0.02, P ¼ 0.89), a significant
effect of drug (Saline vs. Cocaine, F ¼ 31.7, P < 0.0001) but no
group · drug interaction (F ¼ 0.02, P ¼ 0.9). Thus, in the AcbS
cocaine significantly increased spine density to the same extent in the
Home and Novel groups.
Fig. 1. The mean (± SEM) number of crossovers (locomotor activity) during
the 1st and 8th 90 min test sessions in animals given either 15 mg ⁄ kg of
cocaine (j) or saline (h) in their home cage, or 15 mg ⁄ kg of cocaine (d) or
saline (s) in a novel test cage. Activity during the 60 min habituation period is
not shown. There was a significant increase in locomotor activity between the
1st and 8th test session in animals given repeated injections of cocaine in the
Novel condition (i.e. this group sensitized), but no change in animals given
cocaine at Home (i.e. this group failed to sensitize). *Differs from Day 1;
#Differs from the Home-Cocaine group.
Fig. 2. The mean (± SEM) number of dendritic spines per 10 lm on medium
spiny neurons in the core (A) of the nucleus accumbens (AcbC) and the shell
(B) of the nucleus accumbens (AcbS), as a function of treatment condition.
Repeated treatment with cocaine (C) in the Novel condition significantly
increased spine density in the AcbC, relative to saline-treated animals (S).
There was no effect of cocaine treatment in the AcbC in animals given cocaine
at Home. Cocaine increased spine density in the AcbS to the same extent in
animals-treated with cocaine at Home or in the Novel test cage.
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Medial prefrontal cortex. Figure 3 shows the effect of cocaine
treatment on the density of dendritic spines on the basilar and apical
dendrites of layer V pyramidal cells in the mPFC. For the basilar
dendrites, a two-way anova resulted in a significant group · drug
interaction (F ¼ 5.94, P ¼ 0.017). Post hoc Fisher’s tests indicated
that cocaine significantly increased spine density in the Novel group
(P < 0.0001) and in the Home group (P ¼ 0.002), but the significant
interaction indicates that cocaine increased spine density to a
significantly greater extent in the Novel group than in the Home
group (and these two groups differed, P ¼ 0.012, Fisher’s test). For
the apical dendrites, a two-way anova resulted in no significant effect
of group (Home vs. Novel, F ¼ 1.9, P ¼ 0.17), a significant effect of
drug (Saline vs. Cocaine, F ¼ 7.6, P ¼ 0.008) but no significant
group · drug interaction (F ¼ 0.16, P ¼ 0.69). However, post hoc
Fisher’s tests indicated that cocaine significantly increased spine
density in the Novel group (P ¼ 0.029) but the effect in the Home
group was not statistically significant (P ¼ 0.10).
Finally, we used the difference in the number of crossovers between
day 8 of testing and day 1 of testing (day 8 minus day 1) as an index of
the degree of sensitization in individual cocaine-treated animals, and
averaged spine density values from the two hemispheres to obtain one
value per rat, for the purposes of a correlational analysis (complete
data were available from 11 animals ⁄ group). There was a significant
positive correlation between the degree of psychomotor sensitization
and spine density in the AcbC (n ¼ 22, r ¼ 0.52, P ¼ 0.011), but no
other correlations (AcbS, mPFC) were significant.
Experiment 2
Figure 4 shows the dose–response function for locomotor activity
(crossovers) in the Home condition on the first and last (9th) test
session. Animals received a single injection of 30 mg ⁄ kg (or saline)
on the intervening days. There was a marked shift to the left in the
dose–response function between the first and last test session,
indicating that this higher dose of cocaine produced robust psycho-
motor sensitization, even though it was given at home (F ¼ 5.81,
P ¼ 0.005). Figure 5 shows that under these conditions, cocaine also
produced a significant increase in the density of dendritic spines on
medium spiny neurons in both the AcbC (left, t ¼ 2.88, P ¼ 0.009)
and the AcbS (right, t ¼ 4.96, P < 0.0001).
Discussion
When rats were treated repeatedly with 15 mg ⁄ kg of cocaine in the
Home condition there was no significant increase in psychomotor
Fig. 3. The mean (± SEM) number of dendritic spines per 10 lm on the
basilar (A) and apical (B) dendrites of layer V pyramidal cells in the medial
prefrontal cortex, as a function of treatment condition. For basilar dendrites
cocaine treatment increased spine density when given either at Home or in the
Novel condition, but the effect in the Novel group was significantly greater than
in the Home group. For apical dendrites the effect of cocaine treatment was
significant only in the Novel group.
Fig. 4. The mean (± SEM) number of crossovers during the 1st and last (9th)
test session for animals treated in their home cage (experiment 2) with either
saline (open symbols) or escalating doses of cocaine (7.5, 15 and 30 mg ⁄ kg;
filled symbols). During the remaining daily test sessions (2–8) the cocaine-
treated group was given a single injection of 30 mg ⁄ kg of cocaine each day.
Thus, sensitization is indicated here by a shift in the dose–response function
between the 1st and last test session. Note that under these conditions, cocaine
produced robust behavioural sensitization, even though all drug treatments
were given in the home cage.
Fig. 5. The mean (± SEM) number of dendritic spines per 10 lm on medium
spiny neurons in the core (left) of the nucleus accumbens (AcbC) and the shell
(right) of the nucleus accumbens (AcbS), in animals-treated with either saline
or cocaine (30 mg ⁄ kg) at Home (experiment 2). Note that under these
conditions, cocaine treatment significantly increased spine density in both the
AcbC and AcbS.
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effect over time (i.e. this dose failed to induce sensitization), but when
the same dose was given in the Novel condition it induced robust
psychomotor sensitization. These data are consistent with our previous
studies using this environmental manipulation (Badiani et al., 1995;
Browman et al., 1998a), and indicate that in Experiment 1 we
achieved our goal of holding drug history constant while varying the
ability of cocaine to induce psychomotor sensitization. We were able
to ask therefore whether structural plasticity was produced by mere
exposure to cocaine, or whether structural plasticity was associated
with the ability of cocaine to induce psychomotor sensitization. The
answer to this question differed depending on the brain region studied.
Cocaine altered synaptic organization in some brain regions (AcbS
and mPFC) whether it was given in a Novel environment or at Home,
and therefore, independent of whether drug treatment induced
psychomotor sensitization. However, only when cocaine was given
under the condition that promoted psychomotor sensitization did it
change synaptic organization AcbC, and its effect in the mPFC was of
greater magnitude.
The environmental manipulation used here does not gate
sensitization in an all-or-none fashion, but as dose is increased
robust sensitization is seen even when drugs are given at Home.
Environmental context merely shifts the dose–response function for
inducing psychomotor sensitization (Browman et al., 1998a,b). We
predicted therefore that if the dose of cocaine were increased such
that it now induced behavioural sensitization, even when given at
Home, and if structural plasticity in the AcbC is related to the
ability of cocaine to induce sensitization, then under these
conditions cocaine should come to increase spine density in the
AcbC. We confirmed this prediction in experiment 2. Repeated
injections of 30 mg ⁄ kg of cocaine at Home (vs. 15 mg ⁄ kg in
experiment 1) produced robust behavioural sensitization, and
increased spine density in both the AcbC and AcbS.
There are previous studies suggesting that psychomotor sensitiza-
tion preferentially involves alterations in AcbC-related circuitry6 . For
example, Cadoni, Di Chiara and colleagues (Cadoni & Di Chiara,
1999, 2000; Cadoni et al., 2000) have reported that sensitization to
morphine, nicotine, cocaine and amphetamine is associated with
increased dopamine (DA) release in the AcbC (but not AcbS, where in
fact DA is sometimes decreased). Recently Hédou et al., 2002)
reported that amphetamine sensitization is accompanied by increased
Fos expression in the AcbC (and not AcbS). Lastly, the AcbC (and not
AcbS) projects both directly and indirectly to the subthalamic nucleus
(STN) (Zahm, 2000), and locomotor sensitization is associated with
increased c-fos mRNA expression in the STN (Uslaner et al., 2003a7 ).
However, this literature is not consistent and for every example of a
neural correlate of sensitization in the AcbC one can find examples of
a change in the AcbS (e.g. Pierce & Kalivas, 1995; Todtenkopf et al.,
2002). Indeed, even a cursory review of the literature on the
neurobiology of sensitization reveals that many so-called neural
correlates of sensitization have been reported in many brain regions.
Repeated treatment with psychomotor stimulant drugs, using protocols
that induce behavioural sensitization, has been reported to alter nearly
every neurotransmitter system in the Acb, including DA, norepi-
nephrine, 5-HT, acetylcholine, glutamate, GABA, endogenous opioid
transmitters, etc., and a host of intracellular signalling molecules,
growth factors, transcription factors, etc., and many of these changes
have been found in the AcbS as well as the AcbC (Stewart & Badiani,
1993; Pierce & Kalivas, 1997; White & Kalivas, 1998; Wolf, 1998;
Robinson & Berridge, 2000; Vanderschuren & Kalivas, 2000; Kalivas,
2004). However, it is possible that many of these drug-induced
changes in the brain are not actually related to whether the drug
treatments produced sensitization, but occur as a consequence of mere
drug history, and this may account for some of the apparent
inconsistencies in the literature.
To our knowledge, in the entire literature on neurobiological
correlates of sensitization, there has never been an attempt to
dissociate the effects of mere drug history from the ability of drugs
to induce sensitization (with one exception – see below). That is, in
studies that have reported neurobiological correlates of sensitization
(including our own, e.g. Robinson et al., 1988) typically a drug is
given repeatedly, and this induces both sensitization and a change in
some brain measure. However, this procedure does not allow one to
determine whether it was necessary for the drug treatment to induce
sensitization to produce a given change in brain, or whether drug
exposure itself was sufficient, because the effects of mere drug history
are confounded with the effects of drug-induced sensitization
(although there have been attempts to see if treatments that prevent
sensitization also block a given neural correlate of sensitization; e.g.
Wolf et al., 1994). The results reported here clearly establish that mere
exposure to cocaine, in the absence of measurable psychomotor
sensitization, can produce structural plasticity in the AcbS. In contrast,
structural plasticity was seen in the AcbC only if cocaine treatment
also produced sensitization. Given that neuroadaptations responsible
for sensitization may contribute to the transition from casual or
experimental drug use to the compulsive patterns of drug pursuit that
characterize addiction (Robinson & Berridge, 1993; Vanderschuren &
Kalivas, 2000; Robinson & Berridge, 2003; Vezina, 2004), it will be
important to know which drug-induced changes in brain are related to
sensitization, and which are not. Procedures such as those described
here may be valuable in this regard.
We are aware of only one previous study that attempted to
dissociate drug history from sensitization. Pierce et al. (1996)
explicitly divided cocaine-treated animals into those that sensitized
vs. those that did not and then examined effects on the AcbC vs.
AcbS. Interestingly, Pierce et al. (1996) found that a cocaine challenge
increased extracellular glutamate in the AcbC (not AcbS) in animals
sensitized to cocaine, but not in cocaine-treated rats that failed to
develop sensitization. However, one short-coming of this approach as
a method to dissociate drug history from drug-induced sensitization is
that it is impossible to tell whether group differences in the brain are
due to differential drug treatment effects (neural plasticity), or whether
the two groups differed prior to any drug treatment. Indeed, in the
Pierce et al. study (1996), the behavioural response to the first
injection of cocaine was different in the subset of animals that
sensitized than in the subset that did not sensitize (see their table 1),
suggesting pre-existing differences. If differences in the brain in these
selected subgroups reflect two different phenotypes from different
portions of a normally distributed population, this would be akin to
comparing so-called high responder and low responder subgroups,
which also sensitize differentially, but are known to have very
different brains even before they are ever exposed to drug (Piazza
et al., 1998). This problem is avoided in the present study because
animals in the population are assigned randomly to two groups; they
are not selected based on some phenotype.
Nevertheless, it is interesting that Pierce et al. (1996) found that
sensitization increased glutamate release in the AcbC and not AcbS,
because glutamate synapses are found on the heads of dendritic spines,
and in the Acb and mPFC spines are thought to be the locus of
DA ⁄ glutamate interactions (Sesack & Pickel, 1990; Smith & Bolam,
1990; Groenewegen et al., 1991; Goldman-Rakic et al., 1992).
Furthermore, we have found that amphetamine preferentially increases
spine density on the distal portion of the dendritic tree of medium
spiny neurons (Li et al., 2003), which is the location of DA and
glutamate synapses on these cells. Therefore, to the extent that the
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changes in spine density reported here reflect changes in the number of
synapses, which is the case for many other forms of experience-
dependent plasticity (Greenough et al., 1990; Kolb et al., 1998;
Woolley, 1998), our data suggest that sensitization-related changes in
patterns of synaptic connectivity specifically in the AcbC (and mPFC)
may represent the structural basis of changes in DA ⁄ glutamate
signalling that has been associated with sensitization.
Of course, we are assuming that the structural changes in dendritic
spines described here reflect changes in synapses, changes that alter
the operation of the relevant circuits. It is important to acknowledge
therefore that it is impossible to tell how (or if) dendritic reorgani-
zation characterized at this level of structural analysis alters the
operation of cells or circuits. Indeed, very different changes in
structure, such as an increase vs. a decrease in spine density on a given
dendritic segment of a cell, could have exactly the same outcome in
terms of how cell signalling and the operation of the circuit is altered –
depending on how different synaptic inputs are rearranged around the
altered postsynaptic surface. By the same token, apparently similar
alterations in dendrites produced by different treatments could have
very different outcomes for the operation of cells and circuits, if
synaptic inputs are rearranged differently. To determine how the kind
of synaptic reorganization described here alters the operation of cells
and circuits will require both ultra-structural and electrophysiological
approaches. We also do not know the neurobiological mechanisms by
which environmental context modulates drug-induced plasticity.
However, environmental context does modulate the ability of
psychostimulant drugs to induce immediate early genes in many
brain regions (Badiani et al., 1998, 1999; Day et al., 2001; Uslaner
et al., 2003a,8 b), and this could be related to the effect of context on
synaptic plasticity reported here.
Given that this is the first report of a drug-induced change in the
brain that has been specifically linked to whether drug administration
produced sensitization or not, and given that sensitization was
associated specifically with structural plasticity in the AcbC (but not
AcbS), it behoves us to briefly consider what behavioural ⁄ psycholo-
gical functions are mediated by the AcbC vs. the AcbS (Cardinal
et al., 2002). There is increasing evidence that the AcbC is especially
important in mediating the motivational impact of Pavlovian condi-
tioned stimuli (CSs) on behaviour, as assessed by: (i) Pavlovian
conditioned approach – that is, the tendency to approach CSs; (ii)
conditioned reinforcement (CRf) – the process by which a Pavlovian
CS reinforces instrumental responses and (iii) Pavlovian-instrumental
transfer (PIT) – the process by which noncontingent presentation of a
CS facilitates ongoing instrumental actions. Everitt, Robbins and their
colleagues (for reviews, see Everitt et al., 2000; Cardinal et al., 2002)
have found that the AcbC (but not AcbS) is critical for both Pavlovian
conditioned approach (Parkinson et al., 1999; Di Ciano et al., 2001)
and PIT (Hall et al., 2001; de Borchgrave et al., 2002; compare Corbit
et al., 2001), and the noncontingent presentation of a Pavlovian CS
increases extracellular DA in the AcbC, but not AcbS (Ito et al.,
2000). This may be related to reports that AcbC-related circuitry is
critical for the reinstatement of drug-seeking behaviour following
extinction of self-administration (e.g. McFarland & Kalivas, 2001; for
review, see Kalivas & McFarland, 2003). Lesions of both the AcbC
and AcbS impair aspects of CRf, but in different ways – the AcbS
appears to be especially important in mediating the potentiating effects
of psychostimulant drugs on CRf (Parkinson et al., 1999), but the
AcbC appears to be especially important for the ability of conditioned
reinforcers to maintain instrumental actions (Ito et al., 2004). The
AcbS also appears to be especially important in mediating the impact
of primary reinforcers, including food and drugs, as well as aversive
stimuli (Cardinal et al., 2002).
It is especially relevant that all of these aspects of Pavlovian
conditioned motivation have been reported to be enhanced by past
drug treatment (i.e. they appear to sensitize). Prior exposure to
psychostimulant drugs facilitates Pavlovian conditioned approach
(Harmer & Phillips, 1998, 1999; Taylor & Jentsch, 2001), PIT (Wyvell
& Berridge, 2001) and the potentiative effects of psychostimulants on
CRf (Taylor & Horger, 1999; Mead et al., 2004). Indeed, the
facilitatory effects of past drug treatment on the acquisition of drug
self-administration behaviour (Piazza et al., 1989; Horger et al., 1990),
conditioned place preference (Lett, 1989) and progressive ratio
responding (Mendrek et al., 1998; Lorrain et al., 2000) could all be
secondary to sensitization of Pavlovian motivational processes, that is,
to sensitization of incentive salience (Robinson & Berridge, 2000,
2003). Thus, drug-induced synaptic reorganization in the AcbC may
be especially important for both psychomotor sensitization and for
incentive sensitization (assuming that both forms of sensitization are
sensitive to the environmental manipulation used here).
In closing, the extent to which the effects of past drug history on
subsequent behaviour and psychological function are due to
neuroadaptations that accompany the development of any form of
sensitization, vs. those that occur independent of sensitization, is
almost completely unexplored. This is an interesting question given
that the development of psychomotor sensitization has been related
directly to increases in drug motivated behaviour (De Vries et al.,
1998, 2002). Thus, if forms of synaptic plasticity responsible directly
for sensitization play an especially important role in the process by
which repeated drug use leads to addiction, the data reported here
suggest that synaptic reorganization in specifically the AcbC (and
mPFC) may be critically involved in the transition to addiction.
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